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Master’s Thesis Abstract
Characterization of the Ubiquitination of ICER, a Potential Anti-Cancer Protein, in
Human Melanoma Cells
Inducible cAMP Early Repressor (ICER) is a transcriptional repressor that regulates the 
expression of cAMP inducible genes. ICER has recently garnered attention because of 
cAMP’s implication in oncogenesis. ICER is shown to be downregulated in melanomas 
by the means of the ubiquitin-proteasome pathway. It is marked for degradation by 
ubiquitination on its lysine residues. By rescuing ICER levels in cancer cells, it is 
hypothesized that it may be possible to reverse the adverse progression of melanoma 
tumor growth. One possible way of rescuing ICER is by making it unavailable for 
ubiquitination by altering its ubiquitination sites. Special mutant ICERs that have their 
lysines mutated may offer the answer. Consequently, due to its nature as a transcription 
factor, ICER must be localized in the nucleus in order to function properly. Through 
immunocytochemistry, Western blotting, luciferase assay, and TUNEL apoptosis 
analyses of SK-MEL-24 cancer cell lysine knockout mutants, we were able to show 
strong nuclear subcellular localization of our mutant ICERs and efficient binding to 
DNA, a requirement for a transcription factor. This could potentially lead to further study
of ICER as a cancer treatment.
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Introduction
Inducible cAMP Early Repressor (ICER) is a very small transcriptional repressor 
that regulates the expression of cAMP inducible genes. “ICER” is a general term for 
various isoforms ranging in size from 108 to 120 amino acids and resulting from the 
CREM (cAMP Responsive Element Modulator) gene. This protein functions as a 
homodimer to strongly bind DNA and prevent it from being transcribed, effectively 
silencing the genes it regulates. ICER has two specific domains, an N-terminal basic 
leucine zipper domain and a C-terminal DNA binding domain. The latter is known to 
bind to the cAMP response element, or CRE, which is a canonical DNA sequence, 
TGACGTCA, located in cAMP-regulated gene promoters.1
Figure 1. 3D Model of CREB Isoform. A three-dimensional representation of a CREM 
gene isoform binding to DNA as a homodimer.2
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ICER is strongly conserved between species that have it which underlies the 
importance of its function and has become of interest due to cAMP’s implication in 
oncogenesis. Cyclic AMP helps to regulate growth and differentiation of melanocytes, or 
melanin producing epidermal cells, which are responsible for the development of human 
melanoma. One type of ICER, isoform ICER-I □, has already been shown to be absent 
from the nucleus in various cancer cell types, including melanoma. On the other hand, 
ICER levels are strongly elevated in cases of degenerating melanoma cells. This leads to 
the possibility that ICER may potentially play a role in the destruction of melanoma in 
humans.4 In cases of melanoma, ICER is either removed from the nucleus or degraded 
via ubiqutination. Since ubiqutination is dependent on ubiquitin being covalently bound 
to lysine residues on target proteins, we hypothesize that eliminating ubiqutination sites 
may hold the key to rescuing endogenous ICER levels in these cells.5
As a result, recent work has been done to try and establish ICER as a tumor 
suppressor protein. This is due to the phenomena in cancer cells where ICER levels are 
much lower than that of healthy cells. Rescuing ICER levels in these depleted cancer 
cells inhibits growth and negatively impacts the traits that enable cancer cells to grow 
uncontrollably such as rampant DNA synthesis and the upregulation of cell cycle related 
genes. The pathway through which ICER is degraded in cancer cells has also been 
elucidated and is facilitated by the use of the post-translational modifier protein 
ubiquitin.6 In cancers, ICER is either monoubiquitinated, which causes it to be 
sequestered outside the nucleus rendering it useless, or it is polyubiquitinated, which 
causes it to be degraded through the ubiquitination-proteasome pathway.7 In order to be 
affected by these two pathways, ICER needs to be able to be phosphorylated and
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ubiquitinated. Phosphorylation marks ICER for ubiquitination and takes place on serine 
residues within its primary sequence. It has been shown that in the absence of the serine 
residues, ICER levels are higher than when compared to the wildtype. However, 
ubiquitination itself takes place on its lysine residues. Potentially, this means that 
mutating the various lysine residues of ICER into a chemically similar amino acid, such 
as arginine can potentially reduce or eliminate ICER’s ability to be ubiquitinated and
o
degraded.
Lysine
NH2
Arginine
Figure 2. Amino Acids Lysine and Arginine. Both lysine and arginine are polar, 
positively charged amino acids and, under usual circumstances, can be substituted for 
each other without functional protein consequences being observed.
Melanoma is the sixth most common cancer in the United States.9 The prognosis 
for which is very good if the tumor is caught early. However, if the melanoma becomes 
metastatic and spreads to other parts of the body before treatment has started, the rate of 
survival is dramatically reduced.10 Studies have shown that the oncogenes BRAF and 
RAS are responsible for at least 66% of all malignant melanoma cases.11 A mutation in 
the BRAF gene, specifically, V600E, contributes to significant upregulation in the 
mitogen-activated protein kinase (MAPK) pathway. This is significant because ICER is
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involved in the MAPK pathway, which, in turn, is involved in cell division and the 
development of melanoma. Specifically, when this pathway is down regulated, ICER is 
stabilized by cAMP. Alternatively, a consequence of this pathway activation is the 
phosphorylation and ubiquitination of ICER.13 Additionally, forced expression of ICER 
results in an inability for cancer cells to grow in an anchorage-independent manner, 
resulting in inhibited tumor growth.14 Expression of ICER has been linked to 
improvement in other types of cancers, such as leukemia.15 Exclusion of ICER in these 
cases may contribute to the symptoms associated with metastatic melanoma. Logically, 
this leads to the conclusion that rescuing ICER levels in cancerous cells may lead to 
apoptotic death in the affected cells.
The ultimate goal of this study is to determine whether or not various ICER-lysine 
mutants would still be degraded via the same pathway or if they would persist and 
maintain their original function and location in the nucleus of melanoma cells. If the 
mutants do persist, the next step is to investigate the apoptotic effect of ICER on these 
cells.
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Materials and Methods
Cell Transfections for lmmunocytochemistry, Western Blot, Luciferase, and TUNEL
SK-MEL-24 cells were purchased (ATCC) and grown using the Nunc Lab-Tek 
Chamber slide system (Thermo Scientific) until they were 80% confluent. The cells are 
anchorage dependent and adhere to the bottom of the slides. The chambers allowed for 
separation of the cells into distinct populations that would be differentiated based on their 
respective ICER constructs FuGENE HD Transfection Reagent (Promega) was the 
system utilized to transfect the populations. Individual ICER mutant constructs were 
diluted to ~1 pg/pL and mixed with the appropriate amount of FuGENE reagent as per 
the protocol's recommendation in order to form the transfection complex. Once formed, 
the complex was administered to the cells. The total volume of each slide chamber was 
brought up to 25 pL using cell media and left to incubate over 48 hours. The protocol for 
each transfection was the same with the only variable being the proportions of the 
reagents.
lmmunocytochemistry
The cells were grown and transfected as described above. The culture medium 
was removed and the cells were washed two times with phosphate buffered saline (PBS) 
at room temperature. The cells were fixed by adding ~1 mL 4% formaldehyde in PBS 
into the chambers and left for 20 minutes. The formaldehyde was then aspirated and the 
cells were washed with PBS three times for 5 minutes each then stored for several days. 
Two days later, the antigen retrieval buffer was preheated to 95 degrees Celsius and 1 mL
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of the buffer was added to each chamber and the slides were incubated at 95 degrees 
Celsius for 10 minutes. The buffer was aspirated and the cells washed three times with 
PBS. The cells were then incubated in 0.1% Triton X-100 in PBS for 15 minutes at room 
temperature then washed three times with PBS. All remaining PBS was removed and the 
protein block was added and the cells were left to incubate for 1 hour at room 
temperature. Phosphate buffer saline was used to wash the cells again and the primary 
antibody (polyclonal Rabbit anti-HA at 1 pg/mL in blocking buffer) was applied and cells 
left to incubate overnight at 4 degrees Celsius. The next day, the cells were washed four 
times with PBS and the secondary antibody (biotinylated Goat anti-Rabbit Polyvalent - 
Abeam) was applied and the cells left to incubate for 10 minutes at room temperature. 
The cells were again washed four times with PBS then treated with streptavidin 
peroxidase and left to incubate for another 10 minutes at room temperature. The cells 
were then washed four more times with PBS then treated with 30 pL of DAB Chromogen 
and 1.5 mL of DAB Substrate and swirled. After a final incubation for ~10 minutes and 
wash with PBS, a drop of mounting medium was applied and the results observed.
Nuclear and Cytosolic Fractionation
SK-MEL-24 cells were grown in chambers and transfected as described above. 
The culture medium was then aspirated and the cells were washed with 2 mL of PBS at 
room temperature. Next, the cells were harvested by adding 750 pL of trypsin-EDTA and 
incubated at 37 degrees Celsius for three minutes. Then 750 pL/mL of complete cell 
culture media was added and gently pipetted up and down to release the cells from the 
chamber. The cells were transferred to 1.5 mL microcentrifuge tubes and centrifuged at
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500 x g for 5 minutes. Afterwards, the pellets were suspended with 1 mL of ice-cold PBS 
and centrifuged again at 500 x g for 2.5 minutes. The supernatant was discarded and 100 
pL of ice-cold Cytosolic Extraction Reagent I (CER I) was added. The tubes were 
vortexed on high for 15 seconds to resuspend the pellet and then were incubated on ice 
for 10 minutes. Then, 5.5 pL of ice-cold CER II was added to the tubes and the tubes 
were vortexed again on high for 5 seconds and put on ice for 1 minute. Next, the tubes 
were centrifuged for 5 minutes at -16,000 x g. The supernatant (cytosolic extract) was 
transferred to clean, cold tubes and stored at -80 degrees Celsius. The pellet was 
resuspended in 50 pL of ice-cold Nuclear Extraction Reagent (NER). The tubes were 
then vortexed on high for 15 seconds every 10 minutes for 40 minutes. The tubes were 
centrifuged again at -16,000 x g for 10 minutes. The resulting supernatant (nuclear 
extract) was transferred to clean, cold tubes and stored at -80 degrees Celsius.
Western Blot and IR Detection
The protein extracts from the previous sections were analyzed via Western blot. 
Ten pL of the extracts were pipetted into each lane of two sets of polyacrylamide-SDS 
gels and ran at a constant 200 V for 45 minutes. The first set of gels was probed for ICER 
while the next set was probed for beta actin as a loading control. The protein on the 
resulting gel was transferred onto a nitrocellulose membrane at a constant 100 V for one 
hour. Nonspecific antibody protein binding was blocked by incubating the membranes in 
blocking buffer for 15 minutes. For the ICER membranes, the primary rabbit anti-HA 
antibody was added to a 1 pg/mL solution of blocking buffer and incubated at room 
temperature for 6 hours on a swirling platform. The membranes were then washed four
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times for 5 minutes each with PBS containing 0.1% Tween 20 at room temperature. The 
secondary goat anti-rabbit antibody was applied in a 1:10,000 dilution in blocking buffer 
and the membranes left to incubate at room temperature for 45 minutes. Again, the 
membranes were washed four times for 5 minutes each with PBS containing 0.1% Tween 
20. The protocol was then repeated for the beta-actin membranes, using anti-beta actin as 
the sole antibody. The membranes were then analyzed using near-infrared fluorescence 
detection on the Odyssey Imaging System.
Dual Luciferase Reporter Assay
SK-MEL-24 cells were grown in five, twenty-four well dishes in 0.5 mL of media 
per dish. Next, 2 mL of 0.25% trypsin was added to each well for incubated for 5 minutes 
at 37 degrees Celsius and 8 mL of media was added in addition. The cells were then 
transfected as described above. The culture medium was then aspirated and the cells were 
washed with PBS and each well treated with 100 pL of passive lysis buffer. The cells 
were then rocked gently for 15 minutes at room temperature and lysate was transferred to 
new tubes for testing. To activate firefly luciferase, 100 pL of the luciferase assay reagent 
II was added to each tube and the luminometer took a reading five seconds later for about 
ten seconds each. To activate Renilla luciferase, 100 pL of Stop & Glo reagent (Promega) 
was added and measured by luminometer in the same fashion. This was repeated for each 
tube.
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Terminal Deoxynucléotidyl Transferase (TdT) dUTP Nick-End Labeling Assay
SK-MEL-24 cells were grown in chambers and transfected as described above. 
The culture medium was then aspirated and the cells were fixed in 4% formaldehyde in 
PBS for 25 minutes at 4 degrees Celsius. Next, the slides were immersed in PBS twice, 5 
minutes each time. The slides were then immersed in 0.2% Triton X-100 in PBS for 5 
minutes and washed by immersion twice in PBS, 5 minutes each time. Twenty-five pL of 
equilibration buffer was added to the cells at left to incubate at room temperature for 10 
minutes. The cells were then labeled using 25 pL of TdT reaction mixture to each 
population and covered with a cover slip, then incubated in a humidified chamber at 37 
degrees Celsius for 1 hour. Afterwards, the slides were immersed in SSC for fifteen 
minutes to stop the reaction. PBS was then used to wash the slides by immersion three 
times for 5 minutes each. The cells were counterstained with DAPI and analyzed by 
fluorescent microscopy.
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Results
Immunocytochemistry
We utilized immunocytochemistry in order to determine the subcellular 
localization of our mutant ICERs. Nuclear localization of ICER is required for the protein 
to fulfill its function. The results for the GFP control for each one of the slides shows 
very little, if any, ICER signal. Specifically, three out of the five controls showed no 
significant signal while the other two show a relatively light and even distribution of 
ICER throughout both the nucleus and the cytoplasm (Figures 3-7). When analyzing the 
ICER mutants, it is important to note the noticeable difference in the intensity of the 
ICER signal when comparing to the controls. Under normal circumstances, ICER would 
be either present in the nucleus or presumably ubiquitinated and sequestered to the 
cytoplasm. However, almost every ICER mutant shows considerable presence in the 
nucleus and cytoplasm with a strong bias towards the nucleus.
The mutants located in the N-terminal domain, KO-52 through K0-70 (Figure 4), 
of the protein may have less of a dramatic effect on ICER binding and ubiquitination. 
These cells show an ICER signal more prominently than the control but not as much as 
the mutants located in the DNA binding domain. KO-76 through KO-97 (Figures 5-6), 
which happen to be located in the DNA binding domain of ICER, have the highest 
nuclear to cytosolic ratio in terms of signal out of the mutants tested, even more so than 
the complete KO mutants. Interesting though, the HA tagged wildtype cells show a 
convincingly even distribution of ICER throughout. The wildtype cells would be 
expected to more closely resemble the controls than the mutants.
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Control-GFP (C) 20x NHA-wt (Nwt) 20x
CHAnoLys (CKO) 20x CHA-wt (Cwt) 20x
Figure 3. Micrographs of the Control, Nwt, CKO, and Cwt. The GFP control is 
showing a neutral, blank signal throughout all the cells in the field of view. CKO, which 
has an HA tag on the C terminus, shows a strong nuclear signal which may indicate the 
significance of the C terminus in ICER localization. The wildtypes show a strong signal 
but do not show specific ICER localization.
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Control-GFP (C) 20x NHAnoLys-59 (59) 20x
NHAnoLys-52 (52) 20x NHAnoLys-70 (70) 20x
Figure 4. Micrographs of the Control, KO-52, KO-59, and K0-70. These mutants are 
located most closely to the N terminus of ICER. We hypothesize that they may have 
decreased significance in the ubiquitination process due to their location. However, the 
strong ICER localization in the nucleus should be noted.
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Control-GFP (C) 20x NHAnoLys-72 (72) 20x
NHAnoLys-71 (71) 20x NHAnoLys-76 (76) 20x
Figure 5. Micrographs of the Control, KO-71, KO-72, and KO-76. This control is one 
of the few exceptions where there is a noticeable ICER signal and it is only seen in the 
nucleus. As the position of the lysines approach the DNA binding domain, it becomes 
more apparent that their ICER localization is more strongly nuclear than otherwise. This 
would be consistent with the idea that the residues susceptible to ubiquitination in this 
domain are more relevant in ICER processing.
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NHAnoLys-97 (97) 20x 
Figure 6. Micrographs of the Control, KO-87, K0-90, and KO-97. As the mutated 
residues approach the C terminal end, the effect on ICER localization is consistent with 
the previous cells in Figure 5. ICER is predominantly in the nucleus when it would 
otherwise not be, as seen in the control.
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Control-GFP (C) 20x NHAnoLys-106 (106) 20x
NHAnoLys-100(100) 20x NHAnoLys (NKO) 20x
Figure 7. Micrographs of the Control, K0-100, K0-106, and NKO. K0-100 and K0- 
106 most closely resemble the previous mutants with nearby lysine mutations. Of note, 
the NKO mutant can be compared to both the wildtype populations seen previously. The 
ICER distribution here is strong and even distributed throughout the cells.
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Western Blot Analysis
In an effort to provide evidence in support of the immunocytochemistry results, 
Western blots were performed to qualitatively corroborate the significant nuclear 
localization bias of our mutant ICERs. It was expected that the controls, CKO and NKO, 
would have the strongest ICER signal in the nucleus compared to the control and the 
wildtypes. The results show they do appear to have the strongest ICER expression 
indicated by the intensity of their bands, the complete knockouts also have the highest 
concentration of ICER in the nucleus when compared to the other mutants but not the 
wildtypes (Figure 8A). The evidence also confirms the presence of degraded forms of 
ICER in the complete knockouts, which is shown by the less intense bands further south 
on the gel. Concentrations of these degraded proteins are similar to that of the Cwt.
Interestingly, KO-59 has no ICER signal in either extract. This is inconsistent with 
earlier findings from the immunocytochemistry that showed a distributed pattern between 
the two. There is no instance where ICER is completely either in the nucleus or the 
cytosol. The extent of the difference between the signals is what is significant here. K0- 
90 and KO-97 are clear examples of the mutants ICERs showing strong nuclear 
localization. Overall, the bands representing the cytosolic ICER in the mutants are 
definitively less intense than the wildtype and the bands representing the nuclear ICER 
are diminished as well but contain a larger proportion of the overall distribution. This 
supports the hypothesis that the mutants ICERS remain in the nucleus for longer periods 
of time when compared to the wildtype.
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AKO-52 KO-59 K0-70
C N C N C N
KO-71 KO-72 KO-76
C N C N C N
KO-87 K0-90 KO-97
C N C N C N
K0-100 K0-106 NKO
C N C N C N
Control CKO Nwt Cwt
C N C N  C N C N
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Figure 8. Nuclear and Cytosolic Western Blots of ICER Mutants. A) The majority of 
the mutant ICERs have strong nuclear (N):cytosolic(C) ratios. Intensity of the bands 
representing the nucleus appears to be either as strong as or stronger than the cytosolic 
bands. B) The beta-actin bands are loading controls and show consistent protein 
concentration between samples.
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Dual Luciferase Reporter Assay
Perhaps more important than the location of ICER is the efficiency at which it 
binds to DNA and represses gene expression. The ratio of luminescence in this assay is 
the indicator of the efficiency of each of the mutant ICERs. If the ratio is high, ICER is 
repressing less. If the ratio is lower, ICER is repressing more strongly. The data (Figure 
9) indicates that the mutant ICERs are repressing genes more strongly than their wildtype 
counterparts. The wildtype cells had an average ratio of luminescence of about 0.07 while 
every mutant tested was less than 0.02. This is a significant difference in efficiency that 
may be attributed to the inability of the cells to remove ICER from the nucleus. The 
previous data support the assertion that the levels of ICER are elevated in the nucleus of 
these mutants and the luciferase assay seems to suggest that they are more efficient in 
their role as a repressor.
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Figure 9. Dual Luciferase Assay Graphical Representation. The data show a 
significant difference between wildtype ICER efficiency versus the mutants.
18
Terminal Deoxynucleotidyl Transferase (TdT) dUTP Nick-End Labeling Assay
The goal of the TUNEL assay is to show levels of apoptosis in a given cell 
population. Specifically, we are interested in determining if there is a connection between 
rescuing ICER levels and increased apoptosis in melanoma cells. The data presented for 
the TUNEL assay (Figures 10-13) are preliminary and do not currently support our 
hypothesis that stronger nuclear localization of ICER may increase levels of apoptosis in 
melanoma cells. A positive result for apoptosis would look similar to what is seen in the 
control micrograph utilizing DNase I (Figure 10). The coloration is obvious and easy to 
see. However, looking at the micrographs for the mutants, it would seem as if there is a 
negligible effect on the viability of the cells. Out of the hundreds of cells visible using 
DAPI stain, there is no significant data for most mutants. On the other hand, KO-76 and 
KO-87 (Figure 12) have an appreciable signal compared to the rest. Though the signal is 
not as strongly represented in the micrographs as it is in the control, the light green glow 
may indicate the process of apoptosis on some diminished level. This may be evidence 
for further investigating the DNA binding domain. There are only few instances where 
the bright green intensity of the control was seen in the mutant populations. For example, 
KO-71 and KO-76 (Figures 11-12) have nine and three spots of significance, respectively. 
The mutant ICERs’ effect on apoptosis requires further research.
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Control-DNase I (C) DAPI 20x
NHA-wt (Nwt) DAPI 20x
CHA-wt (Cwt) DAPI 20x
pCMV Renilla DAPI 20x
Control-DNase I (C) TUNEL 20x
NHA-wt (Nwt) TUNEL 20x
CHA-wt (Cwt) TUNEL 20x
pCMV Renilla TUNEL 20x
Figure 10. TUNEL Micrographs of the Control, Nwt, Cwt, and pCMV Renilla.
NHAnoLys-52 (52) DAPI 20x
NHAnoLys-59 (59) DAPI 20x
NHAnoLys-70 (70) DAPI 20x
NHAnoLys-71 (71) DAPI 20x
NHAnoLys-52 (52) TUNEL 20x
NHAnoLys-59 (59) TUNEL 20x
NHAnoLys-70 (70) TUNEL 20x
NHAnoLys-71 (71) TUNEL 20x
Figure 11. TUNEL Micrographs of KO-52, KO-59, K0-70, and KO-71.
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NHAnoLys-76 (76) DAPI 20x
NHAnoLys-87 (87) DAPI 20x
NHAnoLys-90 (90) DAPI 20x
NHAnoLys-97 (97) DAPI 20x
NHAnoLys-76 (76) TUNEL 20x
NHAnoLys-87 (87) TUNEL 20x
NHAnoLys-90 (90) TUNEL 20x
NHAnoLys-97 (97) TUNEL 20x
Figure 12. TUNEL Micrographs of KO-76, KO-87, K0-90, and KO-97.
NHAnoLys-100 (100) DAPI 20x
NHAnoLys-106 (106) DAPI 20x
NHAnoLys (NKO) DAPI 20x
NHAnoLys-100 (100) TUNEL 20x
NHAnoLys-106 (106) TUNEL 20x
NHAnoLys (NKO) TUNEL 20x
Figure 13. TUNEL Micrographs of K0-100, K0-106, and NKO.
Discussion
ICER Lysine Mutants are Strongly Localized to the Nucleus o f SK-MEL-24 Cells
Due to its nature as a transcription factor, it is imperative that ICER remains in the 
nucleus of cells in order to provide for its function. Since it has been shown numerous 
times that ICER is marked for ubiquitin-mediated degradation and ICER levels are either 
extremely diminished or absent altogether in cancer cells, we have hypothesized that 
rescuing this protein may have a lethal effect on these cells. We have shown that 
combatting the expulsion of ICER from the nucleus by altering the sites at which it is 
marked for destruction is a viable first step in a path to potentially taking this research a 
step further and developing an ICER based cancer treatment.
Our results for immunocytochemistry are convincing enough to conclude that our 
ICER mutants are resisting ubiquitination. It is interesting that in the majority of 
conditions, there always seems to be a small amount of ICER in the cytoplasm regardless 
of the levels in the nucleus. This is indicated by the pinkish signal seen in all the mutants 
and even the controls. The evidence still strongly points toward the DNA binding domain 
of ICER being the area of most promise. For example, KO-87 and KO-97 (Figure 6) have 
the largest ratio of nuclear to cytosolic ICER. There is almost no signal originating in the 
cytosol. Future research in this area, specifically in this domain, may further elucidate the 
mechanisms involved. Unexpectedly, the NKO and the CKO (Figures 3 and 7) cells have 
ICER in their cytosol. These cells are complete lysine knockouts and if ICER degradation 
based on ubiquitination of the lysine residues was the
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only mode of protein tagging taking place, it is unlikely there would be much, if any, 
ICER present in the cytoplasm. This seems to suggest that some other mechanism is 
either occurring simultaneously and compensating for the diminished efficiency of 
ubiquitination. Many such mechanisms do exist in nature and work in ways similar to 
ubiquitination.16 Examples of two such mechanisms are sumoylation and neddylation.17"18 
These processes utilizing the proteins SUMO and NEDD8, respectively, are in a class 
called “ubiquitin-like proteins” and also modify cellular proteins post-translation, even 
for destruction, similarly to ubiquitination.19 It is possible that these mechanisms, or the 
others that exist, may have contributed to the unexplained levels of ICER in the cytosol.
Western Blot Analysis Confirms Higher ICER Concentration in the Nucleus than Cytosol 
The results from the Western blots are consistent with the conclusions illustrated 
from the immunocytochemistry. Supporting prior evidence, the results show a clear ICER 
localization to the nucleus. When considering previous work that has shown the absence 
of ICER in the nucleus of cancer cells, it is interesting to note the nucleus heavy bias in 
ICER concentration.20 Most of the mutant ICERs tested had nuclear:cytosolic ratios on 
par with that of the control or a more intense ratio favoring the nucleus (Figure 8). This 
provides further evidence to suggest that altering the lysine residues on the protein make 
it more difficult for the cellular machinery to degrade ICER. Due to beta-actin’s nature as 
a cytosolic protein, its strong presence in the nucleus seems to indicate cross 
contamination between the cellular fractions; although under specific cellular conditions, 
beta actin may be present in the nucleus.21 If this were the case, ICER concentration in 
the nucleus may be more diluted in our results than what they actually are. In terms of the
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application of this information, ICER has already been shown to reverse tumor growth in 
rat prostate cancer.22 Establishing the nuclear localization of ICER in human melanoma 
cells is the first step on the way to testing the proteins effect on the viability of the cells 
and hopefully showing that ICER can cause apoptosis in these cells.
ICER Mutants Repress More Strongly than Wildtype ICER
ICER localization in the nucleus is not enough for the mutants to outperform the 
wildtype. In order for this to occur, the mutants must bind with their canonical CRE 
sequence in similar or greater levels. If the mutants were mainly located in the nucleus 
but did not bind to DNA efficiently, their presence would be redundant. The dual 
luciferase assay exhibits the strong repressing power of our mutant ICERs. The controls 
for this experiment indicated by the large bars (Figure 9) show what would be considered 
wildtype levels of ICER efficiency in cells that are already known to be ICER-deficient. 
The data for the mutants support the assertion that the mutants ICERs are much better at 
repressing genes that are transcriptionally affected by ICER. The ratio between firefly 
luciferase:Renilla luciferase is large and provides evidence for strong repression and 
results in the small bars in comparison to the wildtype controls. The conclusion drawn 
from this experiment is that the ICER mutants are much better repressors than the 
wildtype ICER.
As the TUNEL data presented here are preliminary (Figures 10-13), they do not 
currently paint a picture supporting the hypothesis that mutant ICERs will cause 
apoptosis in human melanoma cells on their own. A positive, apoptotic result would have 
shown a vast number of bright green cells in relation to the total number of cells present
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indicated by the DAPI stain. The current data show no real correlation between increased 
mutant ICER localization in the nucleus and the viability of the cells. The lack of any 
appreciable results from this experiment suggests either a scientific dead end or human 
error resulting in misleading data. In either case, more research is needed to further 
investigate the potential link between our mutant ICERs and apoptosis in cancer cells.
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